275 related articles for article (PubMed ID: 10629071)
21. Presence of allelic loss and PTEN mutations in malignant gliomas from Malay patients.
Zainuddin N; Jaafar H; Isa MN; Abdullah JM
Med J Malaysia; 2004 Oct; 59(4):468-79. PubMed ID: 15779579
[TBL] [Abstract][Full Text] [Related]
22. PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.
Fujiwara Y; Hoon DS; Yamada T; Umeshita K; Gotoh M; Sakon M; Nishisho I; Monden M
Jpn J Cancer Res; 2000 Mar; 91(3):287-92. PubMed ID: 10760687
[TBL] [Abstract][Full Text] [Related]
23. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA
Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738
[TBL] [Abstract][Full Text] [Related]
24. Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity.
Mavros A; Hahn M; Wieland I; Koy S; Koufaki ON; Strelocke K; Koch R; Haroske G; Schackert HK; Eckelt U
J Oral Pathol Med; 2002 May; 31(5):270-6. PubMed ID: 12110043
[TBL] [Abstract][Full Text] [Related]
25. Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer.
Yokomizo A; Tindall DJ; Hartmann L; Jenkins RB; Smith DI; Liu W
Int J Oncol; 1998 Jul; 13(1):101-5. PubMed ID: 9625810
[TBL] [Abstract][Full Text] [Related]
26. A commonly deleted region in ovarian cancer on chromosome 19p13.3, not including the OAZ1 gene.
Yanaihara N; Okamoto A; Matsufuji S
Int J Oncol; 2003 Sep; 23(3):567-75. PubMed ID: 12888889
[TBL] [Abstract][Full Text] [Related]
27. Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability.
Fujii H; Matsumoto T; Yoshida M; Furugen Y; Takagaki T; Iwabuchi K; Nakata Y; Takagi Y; Moriya T; Ohtsuji N; Ohtsuji M; Hirose S; Shirai T
Hum Pathol; 2002 Apr; 33(4):421-8. PubMed ID: 12055677
[TBL] [Abstract][Full Text] [Related]
28. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas.
Chiariello E; Roz L; Albarosa R; Magnani I; Finocchiaro G
Oncogene; 1998 Jan; 16(4):541-5. PubMed ID: 9484844
[TBL] [Abstract][Full Text] [Related]
29. Allelic imbalance in chromosome band 18q21 and SMAD4 mutations in ovarian cancers.
Takakura S; Okamoto A; Saito M; Yasuhara T; Shinozaki H; Isonishi S; Yoshimura T; Ohtake Y; Ochiai K; Tanaka T
Genes Chromosomes Cancer; 1999 Mar; 24(3):264-71. PubMed ID: 10451707
[TBL] [Abstract][Full Text] [Related]
30. [Research on the mechanisms of PTEN gene inactivation in ovarian cancer].
Lü QJ; Zhao XD; Song JY; Li XH; Ma Y; Meng H; Jiang WG
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):266-9. PubMed ID: 16181546
[TBL] [Abstract][Full Text] [Related]
31. PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines.
Kondo K; Yao M; Kobayashi K; Ota S; Yoshida M; Kaneko S; Baba M; Sakai N; Kishida T; Kawakami S; Uemura H; Nagashima Y; Nakatani Y; Hosaka M
Int J Cancer; 2001 Jan; 91(2):219-24. PubMed ID: 11146448
[TBL] [Abstract][Full Text] [Related]
32. Analysis of PTEN and the 10q23 region in primary prostate carcinomas.
Feilotter HE; Nagai MA; Boag AH; Eng C; Mulligan LM
Oncogene; 1998 Apr; 16(13):1743-8. PubMed ID: 9582022
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity on chromosome 10q23 and mutation of the phosphatase and tensin homolog deleted from chromosome 10 tumor suppressor gene in Korean hepatocellular carcinoma patients.
Bae JJ; Rho JW; Lee TJ; Yun SS; Kim HJ; Choi JH; Jeong D; Jang BC; Lee TY
Oncol Rep; 2007 Oct; 18(4):1007-13. PubMed ID: 17786367
[TBL] [Abstract][Full Text] [Related]
34. Common genetic changes between endometriosis and ovarian cancer.
Obata K; Hoshiai H
Gynecol Obstet Invest; 2000; 50 Suppl 1():39-43. PubMed ID: 11093060
[TBL] [Abstract][Full Text] [Related]
35. Effects of mutation and expression of PTEN gene mRNA on tumorigenesis and progression of epithelial ovarian cancer.
Chen Y; Zheng H; Yang X; Sun L; Xin Y
Chin Med Sci J; 2004 Mar; 19(1):25-30. PubMed ID: 15104221
[TBL] [Abstract][Full Text] [Related]
36. PTEN gene alterations in lymphoid neoplasms.
Sakai A; Thieblemont C; Wellmann A; Jaffe ES; Raffeld M
Blood; 1998 Nov; 92(9):3410-5. PubMed ID: 9787181
[TBL] [Abstract][Full Text] [Related]
37. Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions.
Li YL; Tian Z; Wu DY; Fu BY; Xin Y
World J Gastroenterol; 2005 Jan; 11(2):285-8. PubMed ID: 15633233
[TBL] [Abstract][Full Text] [Related]
38. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers.
Cairns P; Evron E; Okami K; Halachmi N; Esteller M; Herman JG; Bose S; Wang SI; Parsons R; Sidransky D
Oncogene; 1998 Jun; 16(24):3215-8. PubMed ID: 9671402
[TBL] [Abstract][Full Text] [Related]
39. Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas.
Reifenberger J; Wolter M; Boström J; Büschges R; Schulte KW; Megahed M; Ruzicka T; Reifenberger G
Virchows Arch; 2000 May; 436(5):487-93. PubMed ID: 10881743
[TBL] [Abstract][Full Text] [Related]
40. Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXI1 in human glioblastoma multiforme.
Fults D; Pedone CA; Thompson GE; Uchiyama CM; Gumpper KL; Iliev D; Vinson VL; Tavtigian SV; Perry WL
Int J Oncol; 1998 Apr; 12(4):905-10. PubMed ID: 9499454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]